Murine coronavirus delays expression of a subset of interferon-stimulated genes

Kristine M Rose1, Ruth Elliott, Luis Martínez-Sobrido

  • 1Department of Microbiology, University of Pennsylvania, School of Medicine, 36th Street and Hamilton Walk, Philadelphia, PA 19104-6076, USA.

Journal of Virology
|April 2, 2010
PubMed

Insights

Mouse hepatitis virus (MHV) resists type I interferon (IFN-I) antiviral effects by delaying interferon-stimulated gene induction. MHV inhibits an alternative IFN-I pathway, not the main signaling cascade, impacting IRF-3 function.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Type I interferons (IFN-I) are crucial for controlling viral infections, including coronaviruses.
  • Mouse hepatitis virus (MHV) exhibits cell-type-dependent resistance to IFN-I antiviral activity.
  • Previous studies show MHV replication is inhibited by IFN-I in primary cells but less so in cell lines.

Purpose of the Study:

  • To investigate the mechanisms by which MHV resists IFN-I-mediated antiviral responses.
  • To determine if MHV interferes with interferon-stimulated gene (ISG) induction.
  • To elucidate the specific IFN-I signaling pathways affected by MHV infection.

Main Methods:

  • Infection of cell lines (L2, 293T) and primary cells (macrophages, fibroblasts) with MHV.
  • Treatment with IFN-alpha/beta and superinfection with other RNA viruses (SeV, TMEV, VSV, NDV).
  • Analysis of ISG induction, STAT1-STAT2 phosphorylation, nuclear translocation, and IRF-3 activity.

Main Results:

  • MHV infection delays ISG induction triggered by SeV or IFN-beta when MHV infection precedes exposure.
  • MHV does not block the canonical IFN-beta signaling pathway involving STAT1-STAT2 phosphorylation.
  • MHV partially inhibits IRF-3-dependent transcription, suggesting interference with an alternative IFN-I pathway.

Conclusions:

  • MHV employs a mechanism to evade IFN-I antiviral effects by delaying ISG induction through an alternative pathway.
  • The virus appears to interfere with early ISG induction, potentially by modulating IRF-3 function.
  • Understanding this evasion strategy is critical for developing effective antiviral therapies against coronaviruses.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...